These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38559561)
41. Survival in patients with surgically treated brain metastases: does infratentorial location matter? Hamed M; Potthoff AL; Heimann M; Schäfer N; Borger V; Radbruch A; Herrlinger U; Vatter H; Schneider M Neurosurg Rev; 2023 Mar; 46(1):80. PubMed ID: 36997703 [TBL] [Abstract][Full Text] [Related]
42. Navigating Post-Operative Outcomes: A Comprehensive Reframing of an Original Graded Prognostic Assessment in Patients with Brain Metastases. Goldberg M; Mondragon-Soto MG; Dieringer L; Altawalbeh G; Pöser P; Baumgart L; Wiestler B; Gempt J; Meyer B; Aftahy AK Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254781 [TBL] [Abstract][Full Text] [Related]
43. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer. Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789 [TBL] [Abstract][Full Text] [Related]
44. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases. Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021 [TBL] [Abstract][Full Text] [Related]
45. Treatment of brain metastases from gastrointestinal primaries: Comparing whole-brain radiotherapy and stereotactic radiosurgery in terms of survival. Dincer S; Gurbuz D North Clin Istanb; 2022; 9(1):47-56. PubMed ID: 35340309 [TBL] [Abstract][Full Text] [Related]
46. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis. Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997 [TBL] [Abstract][Full Text] [Related]
47. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases. Carpenter DJ; Leng J; Arshad M; Giles W; Kirkpatrick JP; Floyd SR; Chmura SJ; Salama JK; Hong JC JAMA Netw Open; 2023 Apr; 6(4):e2310117. PubMed ID: 37099292 [TBL] [Abstract][Full Text] [Related]
48. Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups. Trommer M; Adams A; Celik E; Fan J; Funken D; Herter JM; Linde P; Morgenthaler J; Wegen S; Mauch C; Franklin C; Galldiks N; Werner JM; Kocher M; Rueß D; Ruge M; Meißner AK; Baues C; Marnitz S Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267546 [TBL] [Abstract][Full Text] [Related]
49. Impact of removed tumor volume and location on patient outcome in glioblastoma. Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405 [TBL] [Abstract][Full Text] [Related]
50. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940 [TBL] [Abstract][Full Text] [Related]
51. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma. Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530 [TBL] [Abstract][Full Text] [Related]
52. Treatment of five or more brain metastases with stereotactic radiosurgery. Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150 [TBL] [Abstract][Full Text] [Related]